Precigen's (PGEN) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research note released on Wednesday morning, Benzinga reports. Cantor Fitzgerald also issued estimates for Precigen’s FY2024 earnings at ($0.36) EPS. Several other research firms have also recently commented on PGEN. Stifel Nicolaus reissued a buy rating and issued a […]

Related Keywords

Stifel Nicolaus , Vanguard Group Inc , Jpmorgan Chase Co , Iridian Asset Management , Sanders Morris Harris , Patient Capital Management , Opaleye Management Inc , Precigen Inc , Cantor Fitzgerald , Free Report , Get Free Report , Capital Management , Asset Management , Precigen Daily ,